Half Year 2024 Transgene SA Earnings Call TranscriptSep 24, 2024$1.59Earnings- Full Year 2023 Transgene SA Earnings Call TranscriptMar 27, 2024$1.62Earnings
- Half Year 2023 Transgene SA Earnings Call TranscriptSep 20, 2023$1.85Earnings
- Transgene SA Conference Call TranscriptMay 05, 2023
- Full Year 2022 Transgene SA Earnings Call TranscriptMar 16, 2023$0.0101Earnings
- Transgene SA Interim Analysis of TG4001 Phase II Trial Call TranscriptNov 02, 2022
- Transgene SA R&D Day TranscriptSep 27, 2022
- Q2 2022 Transgene SA Earnings Call TranscriptSep 07, 2022$0.0101Earnings
- Q4 2021 Transgene SA Earnings Call TranscriptMar 16, 2022$2.3Earnings
- Transgene SA Corporate Call TranscriptDec 15, 2021
- Transgene SA TG4050 Phase I Studies Results Webcast TranscriptNov 23, 2021
- Q2 2021 Transgene SA Earnings Call TranscriptSep 22, 2021$2.99 (-9.27%)Earnings
- Transgene SA Presents Results From the Phase 1b/2 trial of TG4001 in Combination with Avelumab Conference Call TranscriptNov 12, 2020
- Transgene SA Results from Clinical Study of TG4001 in Combination with Avelumab Conference Call TranscriptJul 22, 2020
- Q4 2019 Transgene SA Earnings Call TranscriptMar 11, 2020$1.44Earnings
Transgene SA R&D Day Transcript
Hello, everyone. Thanks - Thank you very much for being here, either in person via webcast or in the replay. It's a great pleasure to have you here with you today with our management team and our leading clinicians from around the world who will share their enthusiasm on our development.
Today, we have the honor to be hosting Jean-Pierre Delord, MD-PhD, General Manager of IUCT Oncopole of Toulouse; Adel Samson, MD-PhD, Clinical Associate Professor, CAI U.K., Clinician Scientist and Honorary Medical Oncologist for the University of Leeds; and Pedro Romero, MD Chief Editor of the JITC and Deputy Scientific Imaging Director of the Lausanne branch of the Ludwig Institute for Cancer Research, who are here with us in person. Also, Christian Ottensmeier, MD-PhD, FRCP, Professor of Immuno-oncology at the University of Liverpool, The Clatterbridge Cancer Center, NHS Foundation Trust; and Matthew Block, MD-PhD, Medical Oncologist at the Mayo Clinic, who will participate remotely. Having their support today gives us a lot of confidence on the products that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
